BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19028354)

  • 1. Human genetics of osteoporosis.
    Ferrari S
    Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):723-35. PubMed ID: 19028354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of osteoporosis.
    Ralston SH
    Proc Nutr Soc; 2007 May; 66(2):158-65. PubMed ID: 17466098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the genetics of osteoporosis from recent genome-wide association studies.
    Zheng HF; Spector TD; Richards JB
    Expert Rev Mol Med; 2011 Aug; 13():e28. PubMed ID: 21867596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in understanding the genetic susceptibility to osteoporosis.
    Zmuda JM; Cauley JA; Ferrell RE
    Genet Epidemiol; 1999; 16(4):356-67. PubMed ID: 10207717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetics of osteoporosis].
    Urano T
    Nihon Rinsho; 2011 Jul; 69(7):1315-21. PubMed ID: 21774378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the genetics of osteoporosis.
    Williams FM; Spector TD
    J Musculoskelet Neuronal Interact; 2006; 6(1):27-35. PubMed ID: 16675887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic background of osteoporosis].
    Takács I; Lakatos P
    Orv Hetil; 2003 Jul; 144(30):1467-72. PubMed ID: 14569676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of osteoporosis.
    Williams FM; Spector TD
    Acta Reumatol Port; 2007; 32(3):231-40. PubMed ID: 17940498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic regulation of bone mass and susceptibility to osteoporosis.
    Ralston SH; de Crombrugghe B
    Genes Dev; 2006 Sep; 20(18):2492-506. PubMed ID: 16980579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of osteoporosis.
    Huang QY; Kung AW
    Mol Genet Metab; 2006 Aug; 88(4):295-306. PubMed ID: 16762578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture.
    Richards JB; Kavvoura FK; Rivadeneira F; Styrkársdóttir U; Estrada K; Halldórsson BV; Hsu YH; Zillikens MC; Wilson SG; Mullin BH; Amin N; Aulchenko YS; Cupples LA; Deloukas P; Demissie S; Hofman A; Kong A; Karasik D; van Meurs JB; Oostra BA; Pols HA; Sigurdsson G; Thorsteinsdottir U; Soranzo N; Williams FM; Zhou Y; Ralston SH; Thorleifsson G; van Duijn CM; Kiel DP; Stefansson K; Uitterlinden AG; Ioannidis JP; Spector TD;
    Ann Intern Med; 2009 Oct; 151(8):528-37. PubMed ID: 19841454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene variants for osteoporosis and their pleiotropic effects in aging.
    Ferrari SL; Rizzoli R
    Mol Aspects Med; 2005 Jun; 26(3):145-67. PubMed ID: 15811432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
    Mencej-Bedrač S; Preželj J; Marc J
    Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women.
    Bollerslev J; Wilson SG; Dick IM; Islam FM; Ueland T; Palmer L; Devine A; Prince RL
    Bone; 2005 Apr; 36(4):599-606. PubMed ID: 15777745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
    Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
    Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapy.
    Nguyen TV; Center JR; Eisman JA
    Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):481-8. PubMed ID: 18971675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic control of susceptibility to osteoporosis.
    Ralston SH
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2460-6. PubMed ID: 12050200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort.
    Rubin LA; Hawker GA; Peltekova VD; Fielding LJ; Ridout R; Cole DE
    J Bone Miner Res; 1999 Apr; 14(4):633-43. PubMed ID: 10234586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide linkage scan for low spinal bone mineral density in a single extended family confirms linkage to 1p36.3.
    Willaert A; Van Pottelbergh I; Zmierczak H; Goemaere S; Kaufman JM; De Paepe A; Coucke P
    Eur J Hum Genet; 2008 Aug; 16(8):970-6. PubMed ID: 18285824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.